BASAL CELL CARCINOMA (BCC)
Clinical trials for BASAL CELL CARCINOMA (BCC) explained in plain language.
Never miss a new study
Get alerted when new BASAL CELL CARCINOMA (BCC) trials appear
Sign up with your email to follow new studies for BASAL CELL CARCINOMA (BCC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy aims to treat skin cancers without scarring
Disease control Recruiting nowThis study is for people with multiple basal cell carcinoma (a common skin cancer) lesions. It tests a combination of a light-based treatment (blue-light photodynamic therapy) and a pill (sonidegib) to kill cancer cells while avoiding scarring from standard treatments like surger…
Matched conditions: BASAL CELL CARCINOMA (BCC)
Phase: PHASE1 • Sponsor: Nathalie Zeitouni • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
New hope for advanced skin cancer: immunotherapy drug tested as first-line treatment
Disease control Recruiting nowThis study tests whether the immunotherapy drug cemiplimab can shrink or control advanced basal cell carcinoma (a type of skin cancer) when used as the very first treatment. About 34 adults who have not received prior targeted therapy will receive cemiplimab, and researchers will…
Matched conditions: BASAL CELL CARCINOMA (BCC)
Phase: PHASE2 • Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest • Aim: Disease control
Last updated May 13, 2026 15:59 UTC